[
    [
        {
            "time": "",
            "original_text": "6个新冠疫苗品种已开展III期临床试验，疫苗股业绩飙升，如何布局？",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "III期临床试验",
                    "疫苗股",
                    "业绩飙升"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "6个新冠疫苗品种已开展III期临床试验，疫苗股业绩飙升，如何布局？",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "沃森生物今日大宗交易成交6万股，成交价54.11元溢价5.79%",
            "features": {
                "keywords": [
                    "沃森生物",
                    "大宗交易",
                    "溢价"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物今日大宗交易成交6万股，成交价54.11元溢价5.79%",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-02",
            "original_text": "2021年2月疫苗行业纵览：新冠疫苗商业化稳步推进 重磅品种进入收获期",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "商业化",
                    "重磅品种",
                    "收获期"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "2021年2月疫苗行业纵览：新冠疫苗商业化稳步推进 重磅品种进入收获期",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        }
    ]
]